Published in Foodborne Pathog Dis on April 01, 2009
Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother (2012) 1.60
Avian-pathogenic Escherichia coli strains are similar to neonatal meningitis E. coli strains and are able to cause meningitis in the rat model of human disease. Infect Immun (2010) 1.58
Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups. J Clin Microbiol (2012) 1.26
Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis (2011) 1.03
Intermingled Klebsiella pneumoniae Populations Between Retail Meats and Human Urinary Tract Infections. Clin Infect Dis (2015) 0.88
Diarrheagenic Escherichia coli phylogroups are associated with antibiotic resistance and duration of diarrheal episode. ScientificWorldJournal (2015) 0.79
Integron, Plasmid and Host Strain Characteristics of Escherichia coli from Humans and Food Included in the Norwegian Antimicrobial Resistance Monitoring Programs. PLoS One (2015) 0.77
Distribution of Integrons and Phylogenetic Groups among Enteropathogenic Escherichia coli Isolates from Children <5 Years of Age in Delhi, India. Front Microbiol (2017) 0.75
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol (2000) 18.21
Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis (2006) 11.82
Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis (2000) 8.85
Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol (1990) 7.07
The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun (1999) 6.41
Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis (2000) 4.40
The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol (2007) 3.55
Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis (2000) 3.35
Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Appl Environ Microbiol (1983) 2.91
Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother (2003) 2.51
Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis (2007) 2.34
Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J Infect Dis (2006) 2.23
Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J Clin Microbiol (2002) 2.12
Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis (2006) 1.92
Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. J Vet Med B Infect Dis Vet Public Health (2004) 1.79
Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect (2006) 1.73
Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia. Infect Immun (2001) 1.71
Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ (1999) 1.61
Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea. J Antimicrob Chemother (2005) 1.52
Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E. coli isolate enhances its abilities to kill chicken embryos, grow in human urine, and colonize the murine kidney. Infect Immun (2006) 1.49
Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis (2006) 1.45
Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J Clin Microbiol (2003) 1.45
Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J Infect Dis (2002) 1.44
Contamination of retail foods, particularly turkey, from community markets (Minnesota, 1999-2000) with antimicrobial-resistant and extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis (2005) 1.41
Drug-resistant Escherichia coli, Rural Idaho. Emerg Infect Dis (2005) 1.09
Urinary tract infections. Med Clin North Am (1997) 1.09
Resistance to fluoroquinolones in Escherichia coli isolated from poultry. Antimicrob Agents Chemother (1996) 1.01
Virulence factors predict Escherichia coli colonization patterns among human and animal household members. Ann Intern Med (2004) 0.99
Antimicrobial resistance of Escherichia coli isolated from chickens. Vet Microbiol (1989) 0.95
Transmission dynamics and control of severe acute respiratory syndrome. Science (2003) 14.70
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother (2007) 7.81
Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect (2003) 4.63
Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med (2013) 4.55
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis (2005) 4.16
Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med (2004) 3.82
Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial. JAMA (2005) 3.76
The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol (2007) 3.55
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med (2003) 3.54
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol (2005) 3.38
Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis (2002) 3.07
Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis (2002) 2.99
Automatic de-identification of textual documents in the electronic health record: a review of recent research. BMC Med Res Methodol (2010) 2.96
An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis (2002) 2.94
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis (2013) 2.85
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio (2013) 2.64
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol (2012) 2.60
Doxycycline for treatment of community-acquired pneumonia. Clin Infect Dis (2002) 2.48
Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis (2004) 2.40
Antimicrobial resistance determinants and future control. Emerg Infect Dis (2005) 2.36
Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol (2012) 2.22
Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep (2014) 2.15
The Research on Adverse Drug Events and Reports (RADAR) project. JAMA (2005) 2.08
Development of an electronic public health case report using HL7 v2.5 to meet public health needs. J Am Med Inform Assoc (2010) 2.08
Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Microbiol (2008) 2.02
High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol (2012) 2.00
Complications of Foley catheters--is infection the greatest risk? J Urol (2012) 2.00
Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother (2007) 1.95
Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc (2006) 1.93
Interventional study to evaluate the impact of an alcohol-based hand gel in improving hand hygiene compliance. Pediatr Infect Dis J (2002) 1.92
The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med (2002) 1.83
Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol Microbiol (2006) 1.82
Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clin Infect Dis (2004) 1.79
Reduction of inappropriate urinary catheter use at a Veterans Affairs hospital through a multifaceted quality improvement project. Clin Infect Dis (2011) 1.79
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis (2002) 1.77
Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol (2003) 1.73
Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun (2010) 1.72
Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med (2009) 1.72
Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol (2013) 1.72
Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis (2012) 1.69
Clinical and economic outcomes of conventional amphotericin B-associated nephrotoxicity. Clin Infect Dis (2002) 1.67
The genetic structure of Escherichia coli populations in primary and secondary habitats. Microbiology (2002) 1.67
Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J Clin Microbiol (2011) 1.66
Food-borne origins of Escherichia coli causing extraintestinal infections. Clin Infect Dis (2012) 1.65
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis (2010) 1.60
Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol Biol Evol (2004) 1.59
IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun (2002) 1.59
Creatinine production, nutrition, and glomerular filtration rate estimation. J Am Soc Nephrol (2003) 1.57
Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis (2004) 1.56
Loop-mediated isothermal amplification assay for rapid detection of common strains of Escherichia coli. J Clin Microbiol (2008) 1.55
Application of Natural Language Processing to VA Electronic Health Records to Identify Phenotypic Characteristics for Clinical and Research Purposes. Summit on Translat Bioinforma (2008) 1.52
Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician (2011) 1.51
Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology (2013) 1.49
Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E. coli isolate enhances its abilities to kill chicken embryos, grow in human urine, and colonize the murine kidney. Infect Immun (2006) 1.49
Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol (2008) 1.49
Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2005) 1.49
Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother (2006) 1.47
Recurrent catheter-related bloodstream infections: Risk factors and outcome. Int J Infect Dis (2006) 1.47
Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis. J Clin Microbiol (2009) 1.44
Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun (2011) 1.44
Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis (2006) 1.40
Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother (2013) 1.40
Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol (2011) 1.40
Rates of mutation and host transmission for an Escherichia coli clone over 3 years. PLoS One (2011) 1.40
BoB, a best-of-breed automated text de-identification system for VHA clinical documents. J Am Med Inform Assoc (2012) 1.37
Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother (2011) 1.36
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol (2005) 1.36
Informing the front line about common respiratory viral epidemics. AMIA Annu Symp Proc (2007) 1.35
Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn Microbiol Infect Dis (2010) 1.35
Noninvasive optical imaging of staphylococcus aureus bacterial infection in living mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjug Chem (2008) 1.34
Self-assembly of fluorescent inclusion complexes in competitive media including the interior of living cells. J Am Chem Soc (2007) 1.33
Selective recognition of bacterial membranes by zinc(II)-coordination complexes. Chem Commun (Camb) (2006) 1.33
Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother (2007) 1.32
Fluorescent detection of apoptotic cells by using zinc coordination complexes with a selective affinity for membrane surfaces enriched with phosphatidylserine. Chembiochem (2005) 1.32
Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States. Antimicrob Agents Chemother (2004) 1.32
Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. Am J Epidemiol (2005) 1.31
Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother (2005) 1.30
Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun (2007) 1.29
The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrob Agents Chemother (2013) 1.28
Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome. J Clin Microbiol (2013) 1.28
Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration. Int J Antimicrob Agents (2010) 1.28
Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol (2013) 1.28
Optimizing A syndromic surveillance text classifier for influenza-like illness: Does document source matter? AMIA Annu Symp Proc (2008) 1.27
Impact of severity of illness bias and control group misclassification bias in case-control studies of antimicrobial-resistant organisms. Infect Control Hosp Epidemiol (2005) 1.27
Preoperative urine cultures at a veterans affairs medical center. JAMA Intern Med (2013) 1.25
Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance. Clin Infect Dis (2012) 1.24
Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol (2006) 1.23
Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development. Expert Rev Vaccines (2006) 1.21
Complete Genome Sequence of the Epidemic and Highly Virulent CTX-M-15-Producing H30-Rx Subclone of Escherichia coli ST131. Genome Announc (2013) 1.18
Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J Clin Microbiol (2013) 1.17
Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect (2008) 1.16
Enteroaggregative Escherichia coli related to uropathogenic clonal group A. Emerg Infect Dis (2007) 1.14
Colonization with extraintestinal pathogenic Escherichia coli among nursing home residents and its relationship to fluoroquinolone resistance. Antimicrob Agents Chemother (2004) 1.13
Hospital electronic medical record-based public health surveillance system deployed during the 2002 Winter Olympic Games. Am J Infect Control (2007) 1.13
Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community. Infect Control Hosp Epidemiol (2013) 1.12
Developing a manually annotated clinical document corpus to identify phenotypic information for inflammatory bowel disease. BMC Bioinformatics (2009) 1.11
Sepsis from the gut: the enteric habitat of bacteria that cause late-onset neonatal bloodstream infections. Clin Infect Dis (2014) 1.11